Search
+
    SEARCHED FOR:

    VACCINATION PROGRAM

    Sudha Murthy advocates for cervical cancer vaccination, promotes domestic tourism in Rajya Sabha

    Sudha Murty Rajya Sabha (Google Trends): Sudha Murty advocated for a government-sponsored cervical cancer vaccination program for girls aged nine to 14 in her maiden Rajya Sabha speech. She emphasized prevention and highlighted the feasibility of scaling up vaccinations, drawing parallels with the COVID-19 drive. Murty also promoted domestic tourism, urging recognition of Indian heritage sites as World Heritage Sites to boost tourism revenue.

    Sudha Murty calls for govt-backed Cervical Cancer Vaccine Program in her maiden parliamentary speech

    Philanthropist and author Sudha Murty on Tuesday pressed for a government-sponsored vaccination programme to combat cervical cancer. In her maiden speech in the Rajya Sabha, she also pitched for promoting domestic tourism. Murty was nominated by the ...

    SII, the world’s largest vaccine maker, sees demand doubling in five years

    Serum Institute of India Pvt. is gearing up to meet the growing demand for life-saving vaccines, with expectations to double sales in the next five years. The world's largest vaccine maker, based in Pune, currently has the capacity to produce 3 billion doses annually but only sells about half of that. CEO Adar Poonawalla is optimistic about the increasing uptake of vaccines globally as countries boost their healthcare budgets.

    Whooping cough spreading in China, 13 deaths in 2 months. Symptoms and if a vaccine is there

    China experienced a significant surge in whooping cough cases in the first two months of 2024, with 32,380 cases reported compared to 1,421 in the same period in 2023. The disease, caused by Bordetella pertussis, can lead to severe complications.

    Polio Immunization Program extends support to Myanmarese children in Manipur relief camps

    The National Immunization Day, Intensified Pulse Polio Immunization Program 2024 was initiated in Manipur's Kamjong district to provide healthcare services to Myanmarese children seeking refuge. The program targets approximately 3.5 lakh children. It emphasizes the crucial role of the media in spreading awareness and timely administration of vaccines as a collective responsibility.

    Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccine

    Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda's goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda's existing facility in Germany and its partnership with IDT Biologika GmbH.

    The Economic Times
    BACK TO TOP